BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 15381547)

  • 1. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
    Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
    Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
    J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy.
    Abou Ayache R; Thierry A; Bridoux F; Bauwens M; Belmouaz M; Desport E; Touchard G
    Transplant Proc; 2007 Oct; 39(8):2592-4. PubMed ID: 17954185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous and basal cell carcinoma in heart transplant recipients.
    Lampros TD; Cobanoglu A; Parker F; Ratkovec R; Norman DJ; Hershberger R
    J Heart Lung Transplant; 1998 Jun; 17(6):586-91. PubMed ID: 9662094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study.
    Joly P; Bastuji-Garin S; Frances C; Lebbe C; Aubin F; Penso-Assathiany D; D'incan M; Avril MF; Lair G; Barete S; Euvrard S
    Transplantation; 2010 May; 89(10):1224-30. PubMed ID: 20559031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
    Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
    Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.
    Caforio AL; Fortina AB; Piaserico S; Alaibac M; Tona F; Feltrin G; Pompei E; Testolin L; Gambino A; Volta SD; Thiene G; Casarotto D; Peserico A
    Circulation; 2000 Nov; 102(19 Suppl 3):III222-7. PubMed ID: 11082391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation.
    Molina BD; Leiro MG; Pulpón LA; Mirabet S; Yañez JF; Bonet LA; Vilchez FG; Delgado JF; Manito N; Rábago G; Arizón JM; Romero N; Roig E; Blasco T; Pascual D; de la Fuente L; Muñiz J
    Transplant Proc; 2010 Oct; 42(8):3001-5. PubMed ID: 20970593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
    Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
    Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.